None listed
Conditions
Brief summary
The project will examine whether providing clinicians with feedback regarding depression symptoms, generated automatically following computerised depression screening, will result in higher rates of identification of depression, and treatment initation, and decrease rates of depression at 3 months post-screening.
Interventions
All potentially eligible patients undergo computerised depression screening once. Computerised screening involves administration of an individualised depression screen on a portable touchscreen computer, taking approximately 2-5 minutes, completed individually and in their own time in the presence of a research assistant.
Computerised screening begins with the Patient Health Questionnaire (PHQ) 2 item version. If scores on the PHQ2>0, the person is asked the remaining 7 items of the PHQ9.
All potentially eligible patients undergo computerised depression screening once. Computerised screening involves administration of an individualised depression screen on a portable touchscreen computer, taking approximately 2-5 minutes, completed individually and in their own time in the presence of a research assistant. Computerised screening begins with the Patient Health Questionnaire (PHQ) 2 item version. If scores on the PHQ2>0, the person is asked the remaining 7 items of the PHQ9. If total PHQ9 score >4, the person is given a problem list adapted from the Distress Thermometer problem list, and is considered eligible for the randomised controlled trial (RCT; unless suicidal or severe symptoms are expressed - in this case their clinician is always informed about their symptoms). All patients screened are provided with 1 page written feedback regarding the severity of depression symptoms, with contact details regarding relevant stroke and depression services. If eligible for the RCT and allocated to the intervention condition, a written feedback sheet detailing severity of depression, endorsed items on the problem list, and follow up care options is automatically produced and given to the patient's treating clinician immediately following screening.
Sponsors
University of Newcastle
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Confirmed stroke (ischaemic, haemorraghic, other) 2. Current symptoms of depression (Patient Health Questionnaire 9 score of 5 or above)
Exclusion criteria
1. Severe/suicidal symptoms (PHQ9 score of 20 or above, or a score of 1 or above on PHQ9 item 9, thoughts of self harm) 2. Unable to read English 3. Lacks capactity to provide informed consent (e.g. moderate-severe dementia or significant cognitive deficits) 4. Refusal 5. Unavailable for 3 month phone follow-up
Outcome results
None listed